CLVSF - CellaVision AB (publ)

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
651,185
639,340
565,552
471,443
461,772
Cost of revenue
200,042
201,023
173,250
158,402
125,038
Gross profit
451,143
438,317
392,303
313,041
336,734
Operating expenses
Research development
85,833
88,553
64,248
51,253
56,417
Selling general and administrative
194,348
191,498
165,323
151,515
153,742
Total operating expenses
280,181
280,051
229,571
202,768
210,159
Operating income or loss
170,962
158,266
162,732
110,273
126,575
Interest expense
9,745
2,340
1,866
2,546
1,495
Income before tax
159,377
148,429
158,297
112,228
129,220
Income tax expense
33,584
30,094
32,958
22,748
30,048
Income from continuing operations
125,793
118,335
125,339
89,480
99,172
Net income
125,793
118,335
125,339
89,480
99,172
Net income available to common shareholders
125,793
118,335
125,339
89,480
99,172
Basic EPS
-
-
5.25
3.75
4.16
Diluted EPS
-
-
5.25
3.75
4.16
Basic average shares
-
-
23,852
23,852
23,852
Diluted average shares
-
-
23,852
23,852
23,852
EBITDA
-
190,866
193,600
146,812
150,870